pirtobrutinib
eli lilly
['pirto', 'pirtobrutinib', 'cll']
today at #eha2022: pirtobrutinib in heavily pretreated patients with cll/sll and in those with btk c481 mutations! updated data from the bruin study demonstrated deepened responses with an orr of 86% among patients with at least 10 months follow-up 
Real time, on-demand personalized cancer education and support through our online educational platform